HDAC8-IN-16

Overview

HDAC8-IN-16 is a selective histone deacetylase 8 ( HDAC8 ) inhibitor with an IC 50 of 0.16 μM. HDAC8-IN-16 induces cell apoptosis , triggers G 2 /M phase cell cycle arrest, and moderately inhibits cancer cell proliferation. HDAC8-IN-16 is applicable to relevant research on colorectal cancer .

Application

Products | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Colorectal Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > HDAC | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-182035
• CAS No.: 2464465-06-1
• Molecular Formula: C21H24N4O3
• Molecular Weight: 380.44
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source